|Articles|February 15, 2002
Info+: Industry News
Author(s)BioPharm International Editors
Industry news on investors, software validation guidance, mergers and aquisitions, new drugs on the market, a Science Advisory Board that helps vendors understand life-science needs, a new FDA inspection paradigm, and licensing priorities.
Advertisement
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
3
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
4
High-Dose Nusinersen Slows Neurodegeneration in SMA Patients, Study Shows
5